 |
Eligo Bioscience
Last updated: October 12, 2024
Founders: David Bikard and Xavier Duportet
France | Funding: $69.8M (+)
Website: https://eligo-bioscience.com/
A unique platform to engineer and intervene on the microbiome. Eligobiotics are a platform technology that can be programmed to leverage the existing microbial populations in the gut, lungs, vagina, skin, etc. This technology can enable a targeted diagnosis, editing, and functionalization of human or animal microbiomes.
Website: https://eligo-bioscience.com/
A unique platform to engineer and intervene on the microbiome. Eligobiotics are a platform technology that can be programmed to leverage the existing microbial populations in the gut, lungs, vagina, skin, etc. This technology can enable a targeted diagnosis, editing, and functionalization of human or animal microbiomes.
